A Safety and Efficacy Trial of TTHX1114 in People With CED

Clinical trial NCT04812067 · COMPLETED

Trial details

NCT number: NCT04812067
Sponsor: Trefoil Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Corneal Endothelial Dystrophy

Start date: 2021-11-30
Primary completion: 2023-08-29
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.